GU CONNECT expert, Assoc. Prof. Martin Pichler provides a kidney cancer update from ASCO GU 2020 for you.


Kidney cancer update by Assoc. Prof. Martin Pichler, Medical University of Graz, Austria

 

Martin Pichler obtained his MD at the Medical University of Graz in 2006, and his Master of Science in Molecular Biology at the Karl-Franzens University of Graz, Austria. Martin continued his cancer research training in different places, including The UT MD Anderson Cancer Center, Houston, USA (where he is Adjunct Faculty member at the Department of Experimental Therapeutics). He currently works as a medical oncologist with special focus on Urogential- and Gastrointestinal cancer, at the Division of Oncology, Medical University of Graz, Austria. He currently holds the research managing director position of this division and is the Head of the Research Unit for Non-Coding RNAs and Genome Editing in Cancer. His main research focus is to study molecular mechanisms of cancer biology, prognostic biomarker studies and clinical trials. He received several awards, grants and published about 170 peer-reviewed papers so far (forschung.medunigraz.at).
Programme summary
Watch the video now
Other episodes of this series
GU CONNECT: Update from ASCO GU 2020

GU CONNECT: Update from ASCO GU 2020

Episode 1: Prostate Cancer
GU CONNECT Update from ASCO GU 2020

GU CONNECT Update from ASCO GU 2020

Episode 2: Urothelial Cancer
GU CONNECT Update from ASCO GU 2020

GU CONNECT Update from ASCO GU 2020

Episode 3: Kidney Cancer Current Episode
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GU CONNECT

GU CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer and Eisai Europe Limited.

Meet the experts Independent IME approved

Other programmes of interest

publication Publication
Oncology 
LEAP-012 publication

Expert insights on multimodal treatment for intermediate HCC

Experts
Prof. Arndt Vogel
Endorsed by
DiCE Global Liver Institute Blue Faery
ELPA
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jun 2025

This programme has been sponsored by Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of, or speakers involved in this programme.
video Video
Oncology Hemato-oncology 
Innovating relapsed refractory multiple myeloma care

Unmet needs, therapy management, and real-world experience

Experts
Assoc. Prof. María Victoria Mateos, Assoc. Prof. Karthik Ramasamy, Assoc. Prof. Elena Zamagni
  • download Downloadable
    Resources
  • clock 3 MIN
  • calendar Jun 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.
interactive-patient-case Interactive patient case
Oncology 
NTRK fusion testing and treatment in paediatric sarcoma

Make decisions for a young patient during his cancer journey

Experts
Dr Theodore Laetsch
Endorsed by
NTRKers
  • clock 15 MIN
  • calendar Jun 2025

Educational programme supported by an Independent Educational Grant from Bayer.
micro-learning Micro learning

Module

4

of 4

module
Oncology 
Navigating advanced HCC: treatment strategies beyond immunotherapy (IO)

Module 4: Treatment strategies for patients ineligible for IO or those with progression on IO 

Experts
Assoc. Prof. Lorenza Rimassa, Dr Amit Singal
Endorsed by
DiCE ELPA Global Liver Institute
Blue Faery AASLD
  • download Downloadable
    Resources
  • clock 3 MIN
  • calendar Jun 2025

Educational programme supported by an Independent Educational Grant from Bayer.
interactive-patient-case Interactive patient case
Oncology 
Later-line treatment strategies in metastatic colorectal cancer (mCRC)

Rechallenge vs switching

Experts
Prof. Andrea Sartore-Bianchi
Endorsed by
DiCE ICAN international cancer advocacy network
  • clock 15 MIN
  • calendar Jun 2025

Educational programme supported by an Independent Educational Grant from Bayer.
conference-update Conference update
Oncology 
Highlights from ASCO 2025

Expert insights on the latest data 

Experts
Prof. Mark Socinski, Dr Elizabeth Smyth, Dr Paolo Tarantino, Prof. Domenica Lorusso, Prof. Gerhardt Attard
Endorsed by
Exon20group Biomarker Collaborative ICAN international cancer advocacy network
Lung Cancer Europe
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jun 2025

The oncogene-addicted NSCLC supported through an Independent Educational Grant from Bayer with all other updates supported by COR2ED